Biohaven Ltd.
BHVN
$8.26
-$0.11-1.31%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.10% | -8.20% | 38.03% | -23.49% | -29.07% |
| Total Depreciation and Amortization | 4.55% | 56.72% | 1.23% | 55.33% | 29.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.67% | 892.79% | -94.42% | 17.81% | -46.44% |
| Change in Net Operating Assets | -63.34% | -114.68% | 179.62% | -117.04% | 31.00% |
| Cash from Operations | 23.47% | -3.14% | -0.08% | -60.88% | -48.63% |
| Capital Expenditure | 83.67% | 97.87% | 92.10% | -4.77% | 89.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.40% | 277.81% | 83.81% | 385.15% | -2,455.69% |
| Cash from Investing | 84.33% | 276.63% | 84.13% | 384.50% | -2,140.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.91% | -99.85% | -99.66% | -83.25% | 10.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 52.30% | -- | -623.95% | -- | 49.72% |
| Cash from Financing | -30.81% | -99.85% | -22.20% | -89.22% | 11.26% |
| Foreign Exchange rate Adjustments | -100.00% | -- | -471.43% | 483.33% | 128.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 205.69% | 112.56% | 19.72% | 100.23% | -88.49% |